Melanoma cells can spread through the lymphatic system or bloodstream to distant organs. The exact cause of metastasis is not fully understood, but factors that may increase the risk include:
Ultraviolet (UV) radiation exposure, Fair skin and light hair, Family history of melanoma, and Multiple or atypical mole. Metastatic melanoma is a type of skin cancer that has spread from its original site to other parts of the body, such as the lymph nodes, lungs, liver, brain, or bones.
Symptoms of metastatic melanoma can vary depending on where the cancer has spread, but may include:
New or changing skin lesions, Swollen or painful lymph nodes, Cough, shortness of breath, or chest pain (if the lungs are affected), Headaches, seizures, or confusion (if the brain is affected), Bone pain (if the bones are affected), Fatigue. Treatment for metastatic melanoma depends on the stage of the cancer, where it has spread, and your overall health. Options may include: Surgery: To remove the primary tumor and any visible metastases, Chemotherapy: To kill cancer cells, Immunotherapy: To help your body's immune system fight cancer, Targeted therapy: To block specific proteins that promote cancer growth, Radiation therapy: To shrink or destroy cancer cells in specific area.
Metastatic Melanoma on Immunotherapy and outcomes. Initial PET has DX of Metastatic Melanoma. Need type of Immunotherapy, dosages, duration of therapy, follow up PET after start of treatment, 3 to 6 month outcomes, stable, or progressive disease, adverse affects during treatment and death outcome.
Datasets: 20 studies
We are providing a free sample. If you require additional data or data enrichment or have any questions, please contact us directly at sales@onemednet.com
AWS Marketplace now accepts line of credit payments through the PNC Vendor Finance program. This program is available to select AWS customers in the US, excluding NV, NC, ND, TN, & VT.
This listing uses a single pricing dimension called Product Access (Units). It grants you access to the product at no charge. There are no tiers, instance sizes, or usage add-ons to compare. The dimension is a free sample of de-identified medical imaging data for metastatic melanoma. Access follows a one-month subscription. Because only one option exists, pricing does not scale or change based on quantity or usage.
Top-of-mind questions for buyers
What does one unit of Product Access give me?
One unit grants access to the metastatic melanoma dataset, a sample of de-identified medical imaging data. Access runs on a one-month subscription. The data lets you experience the vendor's real-world imaging data before pursuing a larger curated request.
Does my cost change based on how much data I use or download?
No. This dimension is free, so no charges accrue from your usage. There are no tiers, quantity add-ons, or overage points. The dataset is a fixed free sample delivered under a one-month subscription. Cost does not scale with data volume or access frequency.
Is this sample dataset static, or does it update over time?
This published sample is a fixed de-identified imaging dataset for evaluation. Continuous updates and longitudinal cohort streams belong to the vendor's separate curated data services, which are not part of this free listing. For ongoing or custom cohorts, contact the vendor directly.
www.onemednet.com+1
Helpful?
Vendor refund policy
Refunds are not offered for this product.
How can we make this page better?
Tell us how we can improve this page, or report an issue with this product.
Give us feedbackReport a problem with this product or seller
Legal
Vendor terms and conditions
Upon subscribing to this product, you must acknowledge and agree to the terms and conditions outlined in the vendor's End User License Agreement (EULA).
Content disclaimer
Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.
Open, multi-center dataset of 1,597 whole-/total-body FDG-PET/CT studies with 130 CT-derived, expert-verified anatomical segmentations per scan (~250 GB). Provided as anonymized NIfTI (PET, CT, labels) with spreadsheet metadata. Designed for segmentation benchmarking, multi-organ analysis, radiomics, and PET/CT AI research.
Prostate cancer is a type of cancer that develops in the prostate gland, a small walnut-shaped organ located below the bladder in the male reproductive system. The exact cause of prostate cancer is unknown.
Risk factors that may increase the likelihood of cancer are age (most common in men over 65), family history, race (african american men have a higher risk), and hormonal imbalance.
This is a sample dataset containing products listed on the Amazon.com portal in the Pet Supplies category. The full version of this dataset with more than 527,000 products is available upon request.